Tag:
Toll-like receptors
Latest Headlines
Latest Headlines
Merck KGaA nixes development of Idera Pharma cancer drug
Idera Pharmaceuticals' advancement of a Toll-like receptor agonist against cancer has taken a blow. Partner Merck KGaA has informed the developer ( $IDRA ) that the German pharma is ending development
